Congrats to awesome ID educator Dr. Jim Beardsley on his @wakeforestmed Impact Award! He was recognized for making a profound contribution to the academic and professional lives of our med students! #IDTwitter#WeAreID
IDSA awards Dr. @vera_luther, FIDSA a Clinical Practice Innovation Award. Instrumental in advancing IDSA’s antimicrobial stewardship curriculum, Dr. Luther delivers high-quality, evidence-based teaching materials & improves patient care.
Tune in @ 8pm ET: https://t.co/SZdtIK3oU1
Can’t wait to connect with #IDMedEd at #IDWEEK2021. IDSA educators, join the Med Ed COP @IDSAMedEdCOP and our discussion board for an invitation from @MikeMeliaMD to next week’s virtual reception and to participate in our Med Ed survey. @IDSAInfo@UNMC_ID@wakeforestid
Congrats to WF ID docs @vera_luther@ChrisOhlMD & IDSA AS Curriculum Workgroup on their recent CID pub! Great professional society collaboration!! https://t.co/RTy94zw5jn
Congrats to Dr. Enwezor, @wakehealth ID fellow & colleagues on their pub investigating changing attitudes toward the COVID-19 vaccine in NC. Initial intent didn't correlate with vaccine uptake. Keep encouraging vaccination!! #WeAreID
https://t.co/gEofG6DZQp via @MDPIOpenAccess
@WakeForestID is looking forward to the upcoming ID fellowship interview season! Congratulations to Dr. Luther on co-authoring this publication evaluating last year's experiences👇👇👇 https://t.co/a7pqFFtS0v
Welcome to our new first year fellows: Drs. Whitt, Denmeade & Cook! So excited to have you join our ID family @wakehealth !! 😀🥳🎉 #WeAreID#IDtwitter
Interested in working with Doctors Without Borders/Medecins Sans Frontieres? There is an urgent need for Infection Prevention and Control Managers. Checkout this website to learn more: https://t.co/fKUB8hZiZi
Today is #ClinicalTrialsDay. We are thankful for our patients who participate in trials and for our clinical researchers who work diligently to find better ways to prevent, diagnose, and treat cancer.
Learn more about cancer clinical trials @wakehealth: https://t.co/tcSGKjKgZp
Wow 💥💥💥#IDTwitter
NIH clinical trial to test the antibiotic dalbavancin for safety & efficacy in treating omplicated Staphylococcus aureus bacteremia has begun.
DOTS RCT 200 Patients 20 US sites
@BradSpellberg@InfectiousDz https://t.co/HvLR9dUilm